de PNC Financial Services Group Integra LifeSciences IART Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 246 k | Mantener |
15,123
| – | – | ﹤0.01% | 2352 |
|
|
2026
Q2 | USD 272 k | Mantener |
15,123
| – | – | ﹤0.01% | 2236 |
|
|
2026
Q1 | USD 142 k | Vender |
15,123
-1,662
| -10% | -USD 18.2 k | ﹤0.01% | 2572 |
|
|
2025
Q4 | USD 208 k | Mantener |
16,785
| – | – | ﹤0.01% | 2283 |
|
|
2025
Q3 | USD 241 k | Comprar |
16,785
+67
| +0.4% | +USD 918 | ﹤0.01% | 2174 |
|
|
2025
Q2 | USD 205 k | Vender |
16,718
-3,643
| -18% | -USD 52.9 k | ﹤0.01% | 2185 |
|
|
2025
Q1 | USD 448 k | Comprar |
20,361
+606
| +3% | +USD 14.2 k | ﹤0.01% | 1599 |
|
|
2024
Q4 | USD 448 k | Comprar |
19,755
+4,967
| +34% | +USD 108 k | ﹤0.01% | 1623 |
|
|
2024
Q3 | USD 269 k | Vender |
14,788
-5,395
| -27% | -USD 125 k | ﹤0.01% | 1975 |
|
|
2024
Q2 | USD 588 k | Comprar |
20,183
+6,941
| +52% | +USD 206 k | ﹤0.01% | 1402 |
|
|
2024
Q1 | USD 469 k | Vender |
13,242
-255
| -2% | -USD 10.2 k | ﹤0.01% | 1574 |
|
|
2023
Q4 | USD 588 k | Vender |
13,497
-307
| -2% | -USD 12.1 k | ﹤0.01% | 1422 |
|
|
2023
Q3 | USD 527 k | Vender |
13,804
-7,166
| -34% | -USD 301 k | ﹤0.01% | 1446 |
|
|
2023
Q2 | USD 862 k | Vender |
20,970
-2,022
| -9% | -USD 97.3 k | ﹤0.01% | 1222 |
|
|
2023
Q1 | USD 1.32 M | Comprar |
22,992
+124
| +0.5% | +USD 6.99 k | ﹤0.01% | 1011 |
|
|
2022
Q4 | USD 1.28 M | Vender |
22,868
-1,838
| -7% | -USD 93.6 k | ﹤0.01% | 1016 |
|
|
2022
Q3 | USD 1.05 M | Comprar |
24,706
+1,831
| +8% | +USD 93.8 k | ﹤0.01% | 1106 |
|
|
2022
Q2 | USD 1.24 M | Vender |
22,875
-504
| -2% | -USD 30.3 k | ﹤0.01% | 1048 |
|
|
2022
Q1 | USD 1.5 M | Vender |
23,379
-3,755
| -14% | -USD 247 k | ﹤0.01% | 1046 |
|
|
2021
Q4 | USD 1.82 M | Comprar |
27,134
+506
| +2% | +USD 34.2 k | ﹤0.01% | 999 |
|
|
2021
Q3 | USD 1.82 M | Comprar |
26,628
+591
| +2% | +USD 41.8 k | ﹤0.01% | 945 |
|
|
2021
Q2 | USD 1.78 M | Comprar |
26,037
+339
| +1% | +USD 24 k | ﹤0.01% | 968 |
|
|
2021
Q1 | USD 1.78 M | Comprar |
25,698
+1,077
| +4% | +USD 73 k | ﹤0.01% | 926 |
|
|
2020
Q4 | USD 1.6 M | Vender |
24,621
-190
| -0.8% | -USD 10.2 k | ﹤0.01% | 931 |
|
|
2020
Q3 | USD 1.17 M | Vender |
24,811
-4,260
| -15% | -USD 203 k | ﹤0.01% | 980 |
|
|
2020
Q2 | USD 1.37 M | Comprar |
29,071
+2,467
| +9% | +USD 121 k | ﹤0.01% | 915 |
|
|
2020
Q1 | USD 1.19 M | Vender |
26,604
-1,344
| -5% | -USD 70.5 k | ﹤0.01% | 905 |
|
|
2019
Q4 | USD 1.63 M | Vender |
27,948
-21,896
| -44% | -USD 1.3 M | ﹤0.01% | 876 |
|
|
2019
Q3 | USD 2.99 M | Vender |
49,844
-12,288
| -20% | -USD 732 k | ﹤0.01% | 820 |
|
|
2019
Q2 | USD 3.47 M | Comprar |
62,132
+4,368
| +8% | +USD 225 k | ﹤0.01% | 819 |
|
|
2019
Q1 | USD 3.22 M | Vender |
57,764
-972
| -2% | -USD 49.5 k | ﹤0.01% | 874 |
|
|
2018
Q4 | USD 2.65 M | Vender |
58,736
-1,308
| -2% | -USD 71.8 k | ﹤0.01% | 902 |
|
|
2018
Q3 | USD 3.96 M | Comprar |
60,044
+2,300
| +4% | +USD 143 k | ﹤0.01% | 832 |
|
|
2018
Q2 | USD 3.72 M | Vender |
57,744
-1,026
| -2% | -USD 63.5 k | ﹤0.01% | 842 |
|
|
2018
Q1 | USD 3.25 M | Vender |
58,770
-3,341
| -5% | -USD 175 k | ﹤0.01% | 875 |
|
|
2017
Q4 | USD 2.97 M | Comprar |
62,111
+756
| +1% | +USD 37 k | ﹤0.01% | 909 |
|
|
2017
Q3 | USD 3.1 M | Comprar |
61,355
+37,444
| +157% | +USD 1.92 M | ﹤0.01% | 876 |
|
|
2017
Q2 | USD 1.3 M | Vender |
23,911
-274
| -1% | -USD 13.1 k | ﹤0.01% | 1157 |
|
|
2017
Q1 | USD 1.02 M | Comprar |
24,185
+615
| +3% | +USD 26.3 k | ﹤0.01% | 1285 |
|
|
2016
Q4 | USD 1.01 M | Vender |
23,570
-3,818
| -14% | -USD 155 k | ﹤0.01% | 1280 |
|
|
2016
Q3 | USD 1.13 M | Vender |
27,388
-1,964
| -7% | -USD 82.3 k | ﹤0.01% | 1221 |
|
|
2016
Q2 | USD 1.17 M | Vender |
29,352
-1,320
| -4% | -USD 47.5 k | ﹤0.01% | 1198 |
|
|
2016
Q1 | USD 1.03 M | Comprar |
30,672
+7,102
| +30% | +USD 221 k | ﹤0.01% | 1240 |
|
|
2015
Q4 | USD 799 k | Vender |
23,570
-5,152
| -18% | -USD 161 k | ﹤0.01% | 1304 |
|
|
2015
Q3 | USD 855 k | Comprar |
28,722
+2,711
| +10% | +USD 84.8 k | ﹤0.01% | 1289 |
|
|
2015
Q2 | USD 716 k | Comprar |
26,011
+1,414
| +6% | +USD 37.7 k | ﹤0.01% | 1432 |
|
|
2015
Q1 | USD 619 k | Comprar |
24,597
+604
| +3% | +USD 14.3 k | ﹤0.01% | 1498 |
|
|
2014
Q4 | USD 532 k | Comprar |
23,993
+3,748
| +19% | +USD 76 k | ﹤0.01% | 1528 |
|
|
2014
Q3 | USD 411 k | Vender |
20,245
-3,425
| -14% | -USD 68.2 k | ﹤0.01% | 1596 |
|
|
2014
Q2 | USD 456 k | Mantener |
23,670
| – | – | ﹤0.01% | 1490 |
|
|
2014
Q1 | USD 445 k | Comprar |
23,670
+184
| +0.8% | +USD 3.55 k | ﹤0.01% | 1463 |
|
|
2013
Q4 | USD 458 k | Vender |
23,486
-2,515
| -10% | -USD 46.1 k | ﹤0.01% | 1437 |
|
|
2013
Q3 | USD 428 k | Comprar |
26,001
+68
| +0.3% | +USD 1.09 k | ﹤0.01% | 1441 |
|
|
2013
Q2 | USD 388 k | Comprar |
+25,933
| Nuevas | +USD 380 k | ﹤0.01% | 1418 |
|
Otros fondos que tienen IART en su cartera
Posición de PNC Financial Services Group en IART: resumen de T3 2026
PNC Financial Services Group mantuvo sin cambios su posición en Integra LifeSciences (IART) en T3 2026, con 15,123 acciones por un valor de USD 246 k. La posición representa ﹤0.01% de la cartera y ocupa el puesto #2352.
PNC Financial Services Group reportó por primera vez una posición en IART en T2 2013 y la ha mantenido durante 54 trimestres desde entonces. La posición alcanzó su máximo de USD 3.96 M en T3 2018. Al cierre de T3 2026, 86 fondos que sigue Wall St. Rank mantienen una posición en IART.
- Al cierre de T3 2026, PNC Financial Services Group tenía 15,123 acciones de Integra LifeSciences con un valor de USD 246 k.
- PNC Financial Services Group mantuvo sin cambios su número de acciones de Integra LifeSciences en T3 2026.
- Integra LifeSciences representó ﹤0.01% de la cartera de PNC Financial Services Group en T3 2026 y fue su posición número 2352.
- PNC Financial Services Group reportó por primera vez una posición en Integra LifeSciences en T2 2013 y la ha mantenido durante 54 trimestres desde entonces.
- La posición de PNC Financial Services Group en Integra LifeSciences alcanzó su máximo de USD 3.96 M en T3 2018.
- Al cierre de T3 2026, 86 fondos que sigue Wall St. Rank tenían Integra LifeSciences en cartera.
Según el Informe 13F de PNC Financial Services Group correspondiente a T3 2026, presentado el 6 nov 2026.